Acorn Capital Advisors as of June 30, 2026
Portfolio Holdings for Acorn Capital Advisors
Acorn Capital Advisors holds 20 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 21.9 | $80M | 1.1M | 71.05 | |
| Urogen Pharma (URGN) | 16.8 | $62M | 1.7M | 36.80 | |
| Trevi Therapeutics (TRVI) | 10.9 | $40M | 2.1M | 18.65 | |
| Candel Therapeutics (CADL) | 9.8 | $36M | 3.5M | 10.30 | |
| Puma Biotechnology (PBYI) | 9.1 | $34M | 4.1M | 8.11 | |
| Jade Biosceinces Com New (JBIO) | 6.0 | $22M | 987k | 22.22 | |
| Bicara Therapeutics (BCAX) | 5.2 | $19M | 643k | 29.69 | |
| Karyopharm Therapeutics Common Stock (KPTI) | 4.0 | $15M | 1.5M | 9.77 | |
| Onkure Therapeutics Class A Com (OKUR) | 3.5 | $13M | 2.8M | 4.56 | |
| Helus Pharma Com Stk (HELP) | 2.8 | $10M | 1.5M | 6.61 | |
| Protara Therapeutics Com Stk (TARA) | 1.8 | $6.7M | 1.8M | 3.82 | |
| Aura Biosciences (AURA) | 1.8 | $6.6M | 929k | 7.10 | |
| Leonabio Common Stock (LONA) | 1.6 | $5.8M | 635k | 9.19 | |
| Verastem (VSTM) | 1.5 | $5.6M | 1.5M | 3.82 | |
| Aadi Bioscience (WHWK) | 1.4 | $5.2M | 1.1M | 4.58 | |
| Q32 Bio (QTTB) | 0.8 | $2.8M | 216k | 12.74 | |
| Engene Therapeutics (ENGN) | 0.6 | $2.2M | 1.3M | 1.73 | |
| Jasper Therapeuritc (JSPR) | 0.2 | $604k | 1.4M | 0.42 | |
| Bioatla | 0.1 | $448k | 108k | 4.14 | |
| Vyne Therapeutics (VYNE) | 0.0 | $925.965000 | 1.4k | 0.65 |
